Oleoylethanolamide: A Novel Potential Pharmacological Alternative to Cannabinoid Antagonists for the Control of Appetite
Figure 1
(a) and (b) show, respectively, mean cumulative wet mash intake (±S.E.M) and mean time spent in eating activity (±S.E.M) by mice treated with vehicle, OEA 5 mg/kg i.p. (OEA 5), rimonabant 5 mg/kg i.p. (R 5), OEA 10 mg/kg i.p. (OEA 10), and rimonabant 10 mg/kg, i.p. (R 10) over the 45 min BSS, ( vehicle group and both doses of rimonabant and OEA-treated mice). * versus vehicle; # versus OEA 5 (Tukey HSD test).
